期刊文献+

人血小板源性生长因子受体β启动子的结构与功能分析 被引量:2

Structural and Functional Analysis of Human PDGFR-β Promoter
下载PDF
导出
摘要 通过PCR扩增人血小板源性生长因子受体β(PDGFR-β)基因启动子片段,经双酶切后克隆到pGL3-basic载体构建了5个PDGFR-β基因启动子5′系列缺失重组载体,与作为内参的pRL-TK共转染人脐静脉内皮细胞(ECV304,HUVEC)后,通过荧光素酶活性检测鉴定出人PDGFR-β启动子中具有转录调控作用的2个活性区(-983~+53)和(+540~+1457),前者执行正调控,后者则起负调控作用.这2个转录活性区分别含有在人、大鼠、小鼠PDGFR-β基因启动子区都高度保守的区域A-box、B-box和C-box,凝胶迁移或电泳迁移率检测(EMSA)证实,核因子能与B-box*、C-box*特异结合. The promoter of human platelet-derived growth factor-β(PDGFR-β) gene tightly regulated during embryonic development and in several physiological and pathological situations,was identified and characterized.Several deletions of the human PDGFR-β promoter were obtained by PCR from human genomic DNA and then subcloned into pGL3-basic vector containing a luciferase reporter.The recombinant reporters were transiently transfected into the human umbilical vein endothelial cells(ECV304,HUVEC) for the studies of the expression regulatory of this receptor.Two regions(-983 ~ + 53) and(+ 540 ~ + 1457) were identified to regulate human PDGFR-β promoter transcription by luciferase activity assays.The former showed a positive regulatory role,while the latter was negative.The highly conserved regions of human,mouse and rat PDGFR-β core promoters were marked as A-box,B-box and C-box and were found within these two regions.The B-box* and C-box* were observed to specifically bind nuclear factors by electrophoretic mobility shift assays.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2010年第4期347-355,共9页 Chinese Journal of Biochemistry and Molecular Biology
基金 广东省自然科学基金项目(No.7005907) 广东省科技计划项目(No.2008B030301349)~~
关键词 血小板源性生长因子受体β 人脐静脉内皮细胞 启动子 血管生成 platelet-derived growth factor-β human umbilical vein endothelial cells promoter angiogenesis
  • 相关文献

参考文献25

  • 1Li X, Ponten A, Aase K, et al. PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor [ J]. Nat Cell Biol, 2000,2 ( 5 ) : 302-309.
  • 2LaRochelle W J, Jeffers M, McDonald W F, et al. PDGF-D, a new protease-activated growth factor [ J ]. Nat Cell Biol, 2001,3 (5) :517-521.
  • 3Kaplan D R, Chao F C, Stiles C D, et al. Platelet-alpha granules contain a growth factor for fibroblasts[ J]. Blood, 1979, 53(6) :1043-1052.
  • 4Betsholtz C, Karlsson L, Lindahl P. Developmental roles of platelet-derived growth factors [ J ]. Bioessays, 2001,23 ( 6 ) :494- 507.
  • 5Dong J, Grunstein J, Tejada M, et al. VEGF-null cells require PDGFR-alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis [ J]. EMBO J,2004,23(14) :2800-2810.
  • 6Abramsson A, Lindblom P, Betsholtz C. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors [ J ]. J Clin Invest,2003, 112(8) : 1142-1151.
  • 7Kim R, Emi M, Arihiro K, et al. Chemosensitization by STI571 targeting the platelet-derived growth factor/ platelet derived growth factor receptor signaling pathway in the tumor progression and angiogenesis of gastric carcinoma [ J ]. Cancer, 2005, 103 (9) : 1800-1809.
  • 8Roberts W G, Whalen P M, Soderstrom E, et al. Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451 [ J ]. Cancer Res, 2005,65 ( 3 ) :957-966.
  • 9Nissen L J, Cao R, Hedlund E M, et al. Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis [ J ]. J Clin Invest, 2007,117 (10) :2766-2777.
  • 10Cao R, Brakenhielm E, Pawliuk R, et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2[ J]. Nat Med,2003,9(5 ) : 604-613.

同被引文献23

  • 1Tallquist M, Kazlauskas A. PDGF signaling in cells and mice. Cytokine &Growth Factor Reviews,2004,15:205-213.
  • 2Alexander Levitzki. PDGF receptor kinase inhibitors for the treatment of PDGF driven diseases. Cytokine & Growth Factor Reviews,2004,15:229-235.
  • 3Kim R, Emi M, Arihiro K, et al. Chemosensitization by ST1571 targeting the platelet-derived growth factor/platelet derived growth factor receptor signaling pathway in the tumor progression and angiogenesis of gastric carcinoma. Cancer, 2005,103 ( 9 ) : 1800- 1809.
  • 4Ostman A. PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. Cytokine & Growth Factor Reviews,2004,15 (4) ;275-286.
  • 5Dong J, Grunstein J, Tejada M, et al. VEGF-null cells require PDGFR-alpha signaling-mediated stromal fibroblast recruitment for tumorigenesis. EMBO J,2004,23 (14) :2800-2810.
  • 6Abramsson A, Lindblom P, Betsholtz C. Endothelial and nonendothelial sources of PDGFR-β regulate pericyte recruitment and influence vascular pericyte recruitment and influence vascular pattern formation in tumors. J Clin Invest,2003,112(8) :1142-1151.
  • 7Achen M G, Stacker S A. Tumor lymphangiogenesis and metastatic spread-New players begin to emerge. International Journal of Cancer,2006,119 : 1755-1760.
  • 8Cao Y. Direct role of PDGF-BB in lymphangiogenesis and lymphatic metastasis. Cell Cycle,2005,4:228-230.
  • 9Cao R, Bjtimdahl M A, Religa P, et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell ,2004,6 : 333-345.
  • 10Nissen L J, Cao R, Hedlund E M, et al. Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. J Clin Invest, 2007,117 ( 10 ) :2766-2777.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部